Cargando…
Plant-based production of an orally active cyclotide for the treatment of multiple sclerosis
Multiple sclerosis (MS) is a debilitating disease that requires prolonged treatment with often severe side effects. One experimental MS therapeutic currently under development is a single amino acid mutant of a plant peptide termed kalata B1, of the cyclotide family. Like all cyclotides, the therape...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102037/ https://www.ncbi.nlm.nih.gov/pubmed/36930229 http://dx.doi.org/10.1007/s11248-023-00341-1 |